REGRANEX Gel 0.01% (Becaplermin GEL) 0.01% x 15g

Becaplermin, the active ingredient in REGRANEX Gel 0.01%, is a recombinant human platelet-derived growth factor (PDGF). It works by binding to PDGF receptors on fibroblasts and smooth-muscle cells, stimulating chemotaxis, proliferation, and extracellular matrix production. This promotes granulation tissue formation and wound healing, aiding in the repair of diabetic foot ulcers.

The usual dose of REGRANEX Gel 0.01% is determined by your healthcare provider based on the size of your ulcer. It is typically applied once a day to the ulcer. Your doctor will examine your ulcer every 1 to 2 weeks and may adjust the amount of gel as your ulcer heals and grows smaller.

The safety of REGRANEX Gel 0.01% during pregnancy or breastfeeding has not been established. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Your doctor will discuss the potential risks and benefits of using REGRANEX Gel 0.01% in your specific situation.

To order REGRANEX Gel 0.01% from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the import paperwork.

REGRANEX Gel 0.01% is a recombinant human platelet-derived growth factor (PDGF) that promotes wound healing by stimulating granulation tissue formation. It is specifically indicated for diabetic foot ulcers. Other treatments may include debridement, offloading devices, and antibiotics for infections. Your healthcare provider will determine the most appropriate treatment plan for your specific condition.

REGRANEX Gel 0.01% should be stored in the refrigerator at 2 to 8 degrees C (36 to 46 degrees F). Do not freeze the gel. Keep the tube tightly capped when not in use. Do not use REGRANEX Gel 0.01% past the expiration date. Protect the gel from light and ensure it is kept out of reach of children.

REGRANEX Gel 0.01% is applied topically to the ulcer. Wash your hands thoroughly before use. Squeeze the prescribed amount of gel onto a clean, non-absorbable surface like wax paper. Use a clean cotton swab, tongue depressor, or other applicator to spread the gel over the ulcer surface in an even layer. Cover the ulcer with a saline-moistened gauze dressing. After 12 hours, remove the gauze dressing and rinse the ulcer with saline or water to remove excess gel. Apply a new piece of saline-moistened gauze dressing to the ulcer.

The most serious risks to watch for with REGRANEX Gel 0.01% include severe allergic reactions, such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. Other serious risks include an increase in the size of the ulcer, worsening symptoms, and the development of skin cancer or tumors at the application site. Stop using REGRANEX Gel 0.01% and seek medical help immediately if you experience any of these symptoms.

REGRANEX Gel 0.01% should not be used by individuals who are allergic to becaplermin or any of the other ingredients in the gel. It should also not be used by individuals with skin cancer or tumors at the affected area. Inform your doctor if you have poor blood flow to your legs or feet, or a history of cancer, before using REGRANEX Gel 0.01%. Your doctor will determine if REGRANEX Gel 0.01% is appropriate for your specific condition.